Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
GLP-3 Investigation: As research techniques improve, we may finally unlock GLP-3s mysteries
Major studies including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown significant reductions in major adverse cardiovascular events (MACE) in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors
Primary endpoint was percentage of total body weight loss (TBWL%) at the end of the study
This LG II -balancer harbors a transgene driving expression of a red fluorescent protein in somatic nuclei, oxTi564 [ Peft-3::tdTomato::H2B::unc-54 3UTR + Cbr-unc-119(+) ] (FRKJR-JENSEN et al
Summary To comprehensively and accurately evaluate the intervention efficacy of candidate drugs on substance addiction, WuXi Biology has established a robust behavioral testing system for substance use disorders
US$ 29.57
US$ 23.99
US$ 26.58
US$ 25.05
US$ 20.86
US$ 21.58
US$ 21.55
US$ 21.92
US$ 20.51
US$ 24.84
US$ 28.76
US$ 20.68
US$ 29.68
US$ 21.51
US$ 27.15
US$ 28.03
